JBT MAREL CORP (JBTM) Fundamental Analysis & Valuation

NYSE:JBTMUS4778391049

Current stock price

130.27 USD
+4.88 (+3.89%)
At close:
129.29 USD
-0.98 (-0.75%)
Pre-Market:

This JBTM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. JBTM Profitability Analysis

1.1 Basic Checks

  • In the past year JBTM was profitable.
  • In the past year JBTM had a positive cash flow from operations.
  • Of the past 5 years JBTM 4 years were profitable.
  • In the past 5 years JBTM always reported a positive cash flow from operatings.
JBTM Yearly Net Income VS EBIT VS OCF VS FCFJBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

1.2 Ratios

  • The Return On Assets of JBTM (-0.62%) is worse than 68.70% of its industry peers.
  • JBTM's Return On Equity of -1.13% is on the low side compared to the rest of the industry. JBTM is outperformed by 66.41% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.80%, JBTM is doing worse than 64.12% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for JBTM is significantly below the industry average of 10.02%.
Industry RankSector Rank
ROA -0.62%
ROE -1.13%
ROIC 2.8%
ROA(3y)7.79%
ROA(5y)6.83%
ROE(3y)14.51%
ROE(5y)14.91%
ROIC(3y)4.51%
ROIC(5y)5.4%
JBTM Yearly ROA, ROE, ROICJBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • JBTM has a Operating Margin (5.79%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of JBTM has declined.
  • JBTM's Gross Margin of 35.14% is fine compared to the rest of the industry. JBTM outperforms 63.36% of its industry peers.
  • In the last couple of years the Gross Margin of JBTM has grown nicely.
Industry RankSector Rank
OM 5.79%
PM (TTM) N/A
GM 35.14%
OM growth 3Y-12.95%
OM growth 5Y-10.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.82%
GM growth 5Y2.73%
JBTM Yearly Profit, Operating, Gross MarginsJBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

2

2. JBTM Health Analysis

2.1 Basic Checks

  • JBTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for JBTM has been increased compared to 1 year ago.
  • Compared to 5 years ago, JBTM has more shares outstanding
  • JBTM has a better debt/assets ratio than last year.
JBTM Yearly Shares OutstandingJBTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
JBTM Yearly Total Debt VS Total AssetsJBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • JBTM has an Altman-Z score of 1.89. This is not the best score and indicates that JBTM is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.89, JBTM is not doing good in the industry: 68.70% of the companies in the same industry are doing better.
  • JBTM has a debt to FCF ratio of 7.90. This is a slightly negative value and a sign of low solvency as JBTM would need 7.90 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 7.90, JBTM is in line with its industry, outperforming 45.04% of the companies in the same industry.
  • JBTM has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
  • JBTM's Debt to Equity ratio of 0.42 is in line compared to the rest of the industry. JBTM outperforms 56.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 7.9
Altman-Z 1.89
ROIC/WACC0.27
WACC10.31%
JBTM Yearly LT Debt VS Equity VS FCFJBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • JBTM has a Current Ratio of 0.98. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.98, JBTM is doing worse than 87.79% of the companies in the same industry.
  • JBTM has a Quick Ratio of 0.98. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.58, JBTM is not doing good in the industry: 87.79% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.58
JBTM Yearly Current Assets VS Current LiabilitesJBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

6

3. JBTM Growth Analysis

3.1 Past

  • JBTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.10%, which is quite impressive.
  • Measured over the past years, JBTM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.06% on average per year.
  • The Revenue has grown by 121.34% in the past year. This is a very strong growth!
  • JBTM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.06% yearly.
EPS 1Y (TTM)25.1%
EPS 3Y10.26%
EPS 5Y10.06%
EPS Q2Q%16.47%
Revenue 1Y (TTM)121.34%
Revenue growth 3Y33.67%
Revenue growth 5Y17.06%
Sales Q2Q%115.57%

3.2 Future

  • JBTM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.54% yearly.
  • Based on estimates for the next years, JBTM will show a small growth in Revenue. The Revenue will grow by 5.73% on average per year.
EPS Next Y31.31%
EPS Next 2Y22.03%
EPS Next 3Y18.54%
EPS Next 5YN/A
Revenue Next Year6.76%
Revenue Next 2Y5.71%
Revenue Next 3Y5.73%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JBTM Yearly Revenue VS EstimatesJBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
JBTM Yearly EPS VS EstimatesJBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

5

4. JBTM Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 20.42 indicates a rather expensive valuation of JBTM.
  • Based on the Price/Earnings ratio, JBTM is valued a bit cheaper than the industry average as 70.99% of the companies are valued more expensively.
  • JBTM's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.91.
  • Based on the Price/Forward Earnings ratio of 15.55, the valuation of JBTM can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of JBTM indicates a rather cheap valuation: JBTM is cheaper than 80.15% of the companies listed in the same industry.
  • JBTM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.69.
Industry RankSector Rank
PE 20.42
Fwd PE 15.55
JBTM Price Earnings VS Forward Price EarningsJBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JBTM is on the same level as its industry peers.
  • JBTM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 28.44
EV/EBITDA 17.45
JBTM Per share dataJBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as JBTM's earnings are expected to grow with 18.54% in the coming years.
PEG (NY)0.65
PEG (5Y)2.03
EPS Next 2Y22.03%
EPS Next 3Y18.54%

3

5. JBTM Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.32%, JBTM is not a good candidate for dividend investing.
  • JBTM's Dividend Yield is comparable with the industry average which is at 1.21.
  • Compared to an average S&P500 Dividend Yield of 1.89, JBTM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.32%

5.2 History

  • The dividend of JBTM has a limited annual growth rate of 4.31%.
  • JBTM has been paying a dividend for over 5 years, so it has already some track record.
  • As JBTM did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.31%
Div Incr Years0
Div Non Decr Years5
JBTM Yearly Dividends per shareJBTM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0 0 0 0 0

5.3 Sustainability

  • JBTM has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of JBTM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-41.39%
EPS Next 2Y22.03%
EPS Next 3Y18.54%
JBTM Yearly Income VS Free CF VS DividendJBTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

JBTM Fundamentals: All Metrics, Ratios and Statistics

JBT MAREL CORP

NYSE:JBTM (4/8/2026, 8:04:00 PM)

Premarket: 129.29 -0.98 (-0.75%)

130.27

+4.88 (+3.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners100.27%
Inst Owner ChangeN/A
Ins Owners0.72%
Ins Owner Change-1.21%
Market Cap6.77B
Revenue(TTM)3.80B
Net Income(TTM)-50.50M
Analysts83.33
Price Target185.87 (42.68%)
Short Float %5.04%
Short Ratio4.25
Dividend
Industry RankSector Rank
Dividend Yield 0.32%
Yearly Dividend0.5
Dividend Growth(5Y)4.31%
DP-41.39%
Div Incr Years0
Div Non Decr Years5
Ex-Date03-09
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.53%
Min EPS beat(2)0.65%
Max EPS beat(2)26.4%
EPS beat(4)4
Avg EPS beat(4)13.8%
Min EPS beat(4)0.65%
Max EPS beat(4)26.4%
EPS beat(8)5
Avg EPS beat(8)4.07%
EPS beat(12)9
Avg EPS beat(12)5.79%
EPS beat(16)12
Avg EPS beat(16)7.67%
Revenue beat(2)1
Avg Revenue beat(2)2.41%
Min Revenue beat(2)-0.3%
Max Revenue beat(2)5.11%
Revenue beat(4)3
Avg Revenue beat(4)1.77%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)5.11%
Revenue beat(8)4
Avg Revenue beat(8)-1.3%
Revenue beat(12)4
Avg Revenue beat(12)-4.47%
Revenue beat(16)5
Avg Revenue beat(16)-3.58%
PT rev (1m)16.21%
PT rev (3m)16.21%
EPS NQ rev (1m)-3.83%
EPS NQ rev (3m)-5.92%
EPS NY rev (1m)0%
EPS NY rev (3m)6.27%
Revenue NQ rev (1m)-0.6%
Revenue NQ rev (3m)1.49%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)2.22%
Valuation
Industry RankSector Rank
PE 20.42
Fwd PE 15.55
P/S 1.78
P/FCF 28.44
P/OCF 19.82
P/B 1.52
P/tB N/A
EV/EBITDA 17.45
EPS(TTM)6.38
EY4.9%
EPS(NY)8.38
Fwd EY6.43%
FCF(TTM)4.58
FCFY3.52%
OCF(TTM)6.57
OCFY5.05%
SpS73.07
BVpS85.88
TBVpS-20.91
PEG (NY)0.65
PEG (5Y)2.03
Graham Number111.03
Profitability
Industry RankSector Rank
ROA -0.62%
ROE -1.13%
ROCE 3.35%
ROIC 2.8%
ROICexc 2.87%
ROICexgc 15.49%
OM 5.79%
PM (TTM) N/A
GM 35.14%
FCFM 6.27%
ROA(3y)7.79%
ROA(5y)6.83%
ROE(3y)14.51%
ROE(5y)14.91%
ROIC(3y)4.51%
ROIC(5y)5.4%
ROICexc(3y)6.1%
ROICexc(5y)6.48%
ROICexgc(3y)24.22%
ROICexgc(5y)23.15%
ROCE(3y)5.14%
ROCE(5y)6.12%
ROICexgc growth 3Y-3.47%
ROICexgc growth 5Y-12.75%
ROICexc growth 3Y-23.39%
ROICexc growth 5Y-24.79%
OM growth 3Y-12.95%
OM growth 5Y-10.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.82%
GM growth 5Y2.73%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 7.9
Debt/EBITDA 3.87
Cap/Depr 38.92%
Cap/Sales 2.73%
Interest Coverage 2.21
Cash Conversion 70.27%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.58
Altman-Z 1.89
F-Score3
WACC10.31%
ROIC/WACC0.27
Cap/Depr(3y)47.22%
Cap/Depr(5y)64.88%
Cap/Sales(3y)2.75%
Cap/Sales(5y)3.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.1%
EPS 3Y10.26%
EPS 5Y10.06%
EPS Q2Q%16.47%
EPS Next Y31.31%
EPS Next 2Y22.03%
EPS Next 3Y18.54%
EPS Next 5YN/A
Revenue 1Y (TTM)121.34%
Revenue growth 3Y33.67%
Revenue growth 5Y17.06%
Sales Q2Q%115.57%
Revenue Next Year6.76%
Revenue Next 2Y5.71%
Revenue Next 3Y5.73%
Revenue Next 5YN/A
EBIT growth 1Y83.72%
EBIT growth 3Y16.36%
EBIT growth 5Y4.74%
EBIT Next Year75.71%
EBIT Next 3Y29.74%
EBIT Next 5YN/A
FCF growth 1Y21.67%
FCF growth 3Y60.4%
FCF growth 5Y1.81%
OCF growth 1Y46.28%
OCF growth 3Y33.91%
OCF growth 5Y6.28%

JBT MAREL CORP / JBTM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for JBT MAREL CORP?

ChartMill assigns a fundamental rating of 4 / 10 to JBTM.


What is the valuation status of JBT MAREL CORP (JBTM) stock?

ChartMill assigns a valuation rating of 5 / 10 to JBT MAREL CORP (JBTM). This can be considered as Fairly Valued.


What is the profitability of JBTM stock?

JBT MAREL CORP (JBTM) has a profitability rating of 3 / 10.


How financially healthy is JBT MAREL CORP?

The financial health rating of JBT MAREL CORP (JBTM) is 2 / 10.


What is the expected EPS growth for JBT MAREL CORP (JBTM) stock?

The Earnings per Share (EPS) of JBT MAREL CORP (JBTM) is expected to grow by 31.31% in the next year.